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Abstract
Parkinson disease is caused by neuronal loss in the substantia nigra which manifests by abnormality of movement, muscle
tone, and postural stability. Several genes have been implicated in the pathogenesis of Parkinson disease, but the
underlying molecular basis is still unknown for ,70% of the patients. Using homozygosity mapping and whole exome
sequencing we identified a deleterious mutation in DNAJC6 in two patients with juvenile Parkinsonism. The mutation was
associated with abnormal transcripts and marked reduced DNAJC6 mRNA level. DNAJC6 encodes the HSP40 Auxilin, a
protein which is selectively expressed in neurons and confers specificity to the ATPase activity of its partner Hcs70 in clathrin
uncoating. In Auxilin null mice it was previously shown that the abnormally increased retention of assembled clathrin on
vesicles and in empty cages leads to impaired synaptic vesicle recycling and perturbed clathrin mediated endocytosis.
Endocytosis function, studied by transferring uptake, was normal in fibroblasts from our patients, likely because of the
presence of another J-domain containing partner which co-chaperones Hsc70-mediated uncoating activity in non-neuronal
cells. The present report underscores the importance of the endocytic/lysosomal pathway in the pathogenesis of Parkinson
disease and other forms of Parkinsonism.
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Introduction
Parkinson’s disease (PD) is an insidious and progressive
neurodegenerative disorder causing slowed movement, tremor,
rigidity and postural instability. The disease is characterized by
neuronal loss in the substantia nigra and other brain regions, and
is usually associated with the formation of intracellular protein
inclusions in damaged neurons, known as Lewy bodies. Several
genes known to function in the endocytic/lysosomal pathway or in
mitochondrial repair/elimination machinery have been implicated
in the pathogenesis of PD. At present, known Mendelian forms
and genetic risk factors of PD explain only about 30% of the
disease risk at the general population level [1]. While familial
forms of PD and Juvenile variants are rare, the identification of
their disease-causing genes is important as they highlight specific
pathways and because common genetic variants in these genes
may confer a risk of developing the sporadic disease. Here, we
report a homozygous mutation in DNAJC6 in two patients with
autosomal-recessive juvenile Parkinsonism.
Results
In order to localize the mutated gene in this family we searched
for homozygous regions common to the two patients but not to
their healthy brother, by genotyping dense DNA SNP arrays. This
analysis resulted in identification of eight homozygous genomic
regions of more than 2 Mb each, totaling 102.75 Mb. These
regions encompass about 800 protein-coding genes, making the
identification of plausible candidate genes difficult. We therefore
performed whole exome sequencing of patient II-2 sample. This
analysis resulted in the identification of 18,494 coding variants
(single-nucleotide variants and small insertions and deletions) of
which 7,387 variants were homozygous, but only 740 homozygous
coding or splice site variants were present in the eight homozygous
regions. Thirty variants were not annotated in dbSNP132, in the
1,000-genome or in our in-house database, and 15 remained after
filtering out synonymous changes. Sanger sequencing confirmed
only 11 changes and these segregated with the disease within the
family. However, out of the 11 variants, ten were annotated in
dbSNP135. We further checked for their conservation score
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six variants was above 3.0 and these were tested for their potential
pathogenicity using Polyphen, SIFT, and Mutation taster
software. Three variants were reported by these tools as potentially
pathogenic: Arg141Cys mutation in POLR1C (rs148385032),
Cys3346Arg in PKHD1 (rs149798764), and c.801 22A .G
mutation in DNAJC6 (at chr.1:65623981). Mutations in POLR1C
were recently shown to cause Treacher Collins syndrome [2] and
PKHD1 mutations are associated with polycystic kidney and
hepatic disease [3] and were thus excluded as candidate genes for
PD. Of note the index case had normal kidneys as per abdominal
ultrasound and did not display the facial characteristics of
Treacher Collins syndrome. The c.801-2 A2.G mutation in
the DNAJC6 gene segregated with the disease state within the
family; both patients were homozygous, while the parents and two
healthy siblings were heterozygous for the mutation; one sister was
homozygous for the normal allele (figure 1A–C). The mutation
was not carried by any of 208 anonymous ethnic matched
controls, neither was it present in the data of the 5379 Exomes
available at the NHLBI Exome Sequencing Project website
Release Version: v.0.0.9.
DNAJC6 encodes Auxilin which belongs to the evolutionarily
conserved DNAJ/HSP40 family of proteins [4]. These proteins
regulate molecular chaperone function by stimulating ATPase
activity in many cellular processes and Auxilin functions
specifically in the Clathrin Mediated Endocytosis (CME) pathway
(figure 2). DNAJC6 consists of 19 exons which encode 970 amino
acids. The effect of the mutation on cDNA was studied in RNA
from the lymphoblast cell line and from cultured skin fibroblasts of
patient II-4. Homozygosity for the c.801 22A 2.G mutation
resulted in the generation of two mis-spliced cDNA transcripts; an
in-frame exon 7-skipped transcript lacking amino acids 268–328,
and an out-of-frame transcript with an insertion of the last 91
nucleotides of IVS 6 (c.801 291) between exon 6 and 7, resulting
in the addition of eight non-synonymous residues before reaching
a termination codon. Importantly, the normally-spliced transcript
was undetectable (figure 1E–F). This is suggestive but does not
confirm pathogenicity of the c.801 22A 2.G mutation within
the family. Nonetheless, the ratio of DNAJC6 cDNA normalized to
beta-actin cDNA of five controls was 0.064+/20.007 whereas the
ratio was 0.011 in the patient, indicating a significant instability of
the DNAJC6 mRNA in the patient’s cells.
Discussion
CME is a major pathway for the internalization of selected
protein cargo from the plasma membrane to membrane-bound
internal compartments. The cargo, mainly receptors and their
bound ligands, is recruited to nascent clathrin-coated pits, which
then mature, invaginate, and ultimately undergo fission to produce
Clathrin-Coated Vesicles (CCVs) [5,6]. Once the vesicle has
pinched off from the plasma membrane, the coat is lost and its
components are recycled. The vesicle itself then fuses with the
membrane of a target compartment. The shedding of the coat,
which occurs almost immediately after the endocytic CCV buds
from the plasma membrane, is driven by ATP hydrolysis and is
important for clathrin recycling [7,8]. The necessary ATPase
activity is contributed by Hsc70, which like all Hsp70 homologues,
interacts with J-domain containing cochaperones that specify its
targets. In the case of clathrin coats, the relevant J-domain protein
is Auxilin [9]. Three functional domains are instrumental for
Auxilin’s co-chaperone activity: an N-terminal PTEN-like domain
(residues 40–421), which is important for recruitment of Auxilin
onto CCVs, a middle domain which binds clathrin, and a
Figure 1. The c.801 22A 2.G mutation in the DNAJC6 gene. The green arrow points at the first nucleotide of exon 7 and the mutation
affects the preceding AG splice acceptor site of intron 6 which is changed to GG in the patient (A). The sequence of an obligate heterozygote is
shown in (B) and that of a control in (C). Schematic representation of the mutation site at the genomic level (D) and its impact on the cDNA (E).
Chromatogram of cDNA from a patient encompassing the 39 junction of exon 6 (F) and demonstrating a transcript lacking exon 7 and another
transcript where nNext to the last base of exon 6 (blue arrow) overlapping exon 8 sequence is the intronic sequences from intron 6 (c.801 291). The
normal exon 6/exon 7 spliced form is undetectable.
doi:10.1371/journal.pone.0036458.g001
Auxilin-Related Parkinsonism
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36458carboxyl-terminal J-domain (residues 886–931) which binds Hsc70
[10,11]. The low mRNA level in our patients and the production
of two abnormal transcripts lacking either a significant part of the
PTEN-like domain or the carboxyl-terminal J-domain, suggest
that cells homozygous for the c.801-2 A2.G mutation lack the
Auxilin protein.
Auxilin is selectively expressed in neurons and is enriched in
nerve terminals [12]. In non-neuronal cells, another J-domain
containing partner, the ubiquitously expressed cyclin-G-dependent
kinase (GAK), co-chaperones Hsc70-mediated uncoating activity
on CCV [13]. Reduction of Auxilin and its homologue GAK was
shown to result in the impairment of CME and of the clathrin-
dependent traffic of cargo from the Golgi to the lysosome [14].
Nonetheless, Auxilin is not redundant in mice and Auxilin null
mice exhibit an abnormally increased retention of assembled
clathrin on vesicles and in empty cages despite upregulation of
GAK. This defect, in turn, leads to impaired synaptic vesicle
recycling and perturbed CME, probably because of sequestration
of clathrin coat components and their accessory factors with failure
to form new clathrin-coated pits [15]. Mice lacking Auxilin have a
high rate of unexplained early postnatal mortality, and surviving
pups fail to thrive though they do have normal life span. We
examined brain tissue of these Auxilin null mice but could not
detect any alteration in substantia nigra morphology, dopamine
transporter abundance or distribution (data not shown), in
agreement with the lack of any gait or movement abnormalities
in the mutant mice. Lack of neurodegeneration in transgenic mice
that express mutated versions of PD genes is a recognized
phenomenon in PD research [16].
The identification of the molecular basis of familial PD and
juvenile variants is still in progress [17]. Loss of-function mutations
in PRKN, PINK1, and DJ-1, all implicated in mitochondrial
repair/elimination machinery, give rise to a pure, early onset PD.
Another group of PD-causing genes participate in the endosomal/
lysosomal pathway. a-synuclein, encoded by SNCA, was shown to
participate in synaptic vesicle formation and recycling and to
facilitate CME [18]. The C. elegance orthologue of LRRK2,
another central player in PD pathogenesis, regulates the proper
localization of synaptic vesicles in neurons [19]. Dominant
mutations in PD patients were recently identified in VPS35,a
component of the retromer complex which mediates retrograde
transport between endosomes and the trans-Golgi network
[20,21]. Another player in the endosomal/lysosomal compart-
ment, ATP13A2, is also associated with PD [22]. Finally,
mutations in the gene encoding the lysosomal enzyme glucocere-
brosidase, which interacts with a-synuclein [23], have also been
identified as PD susceptibility alleles [24]. The involvement of
these five genes underscores the role of the endosomal/lysosomal
pathway in PD pathogenesis. We propose that Auxilin is a new
endosomal/lysosomal Parkinsonism-related gene. We refrain from
the term ‘‘Parkinson Disease’’ since the patients did not respond to
L-Dopa. Since dopamine receptors undergo CME [25] followed
by endosomal sorting to recycling or degradation [26], it is
conceivable that a homozygous deleterious mutation in the Auxilin
encoding gene, DNAJC6, would give rise to abnormal dopamine
receptor metabolism with the resultant parkinsonism. We studied
the endosomal system in fibroblasts of patient II-2 by measuring
transferrin uptake but observed no differences in either the levels
or the pattern of transferrin uptake between control and mutant
cells suggesting that in human fibroblasts Auxilin is redundant and
its activity overlaps that of GAK.
DNAJC6 does not fall within any of the peaks discovered by
recent PD genome-wide association studies. Focused studies on
common variation in this gene are perhaps now warranted [27].
We determined the sequence of the coding exons and splice sites of
DNAJC6 in 15 patients with PD onset before 40 years of age but
could not find any pathogenic mutation.
In summary, using homozygosity mapping in a consanguineous
small family, followed by whole exome sequencing of a single
patient who suffered from juvenile Parkinsonism, we were able to
identify a new Parkisnsonism-related gene. It is likely that DNAJC6
is indispensible in the human substatia nigra but is redundant in
peripheral tissues. Nevertheless, the findings presented above are
Figure 2. Schematic representation of clathrin-mediated endocytosis. Plasma membrane molecules (in this case the dopamine receptor)
associate with nascent clathrin-coated pits which then mature invaginate and finally pinch off to form clathrin-coated vesicles. The shedding of the
coat takes place after the vesicle buds from the plasma membrane. This process is driven by Hsc70 ATP hydrolysis activity which is recruited to
clathrin coats by Auxilin. The uncoated vesicle fuses with the membrane of a target compartment and delivers its cargo. Clathrin molecules are
directed to the plasma membrane for re-use.
doi:10.1371/journal.pone.0036458.g002
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family, and emphasize the role of CME in the pathogenesis of PD.
Materials and Methods
Clinical description
The proband, patient II-4, presented at 13 years of age along
with his 18 year old brother, patient II-2.The two brothers were
the sons of first cousin Arab-Moslem parents of Palestinian origin
(figure 3). The parents and three siblings were healthy. Pregnancy,
delivery and early psychomotor development of the two patients
was normal. On physical examination at 11 years, patient II-4 was
first noted to have debilitating bradykinesia, rigidity, postural
instability, hypomimia, and asymmetric tremor at rest. Therapeu-
tic trials with Amantadine, Pramipexole, and L-Dopa did not
provide any relief and the patient became wheel-chair bound at
age 13. Despite being cognitively normal he could not attend
school due to his physical impairment. Patient II-2 was reported to
suffer from identical symptoms during childhood and had
deteriorated to a dependent state by age 18. The course of his
disease was more insidious with bradykinesia noted at 7 years and
later appearance of rigidity, tremor and postural instability. The
physical examination of both patients revealed hypomimia, slow
and dysarthric speech, bradykinesis, pill-rolling tremor at rest, and
postural instability with inability to walk. Glabellar tap was
unextinguishable and no gaze paresis was elicited. In patient II-2
hypometric saccades were noted. Tone was increased in limbs with
no spasticity, pyramidal signs or dystonia. Deep tendon reflexes
were symmetric and normal. Plantar reflexes were downgoing.
Fine alternating movements, finger and foot tapping were slow
and reduced in amplitude. No cerebellar or sensory deficits were
found. Brain Magnetic Resonance Imaging (MRI) was unremark-
able in both patients. The parents, another brother and two sisters
were healthy at ages 11 to 21 and had normal neurologic
examinations.
The study was approved by the Hadassah Institutional Review
Board and the Ministry of Health. The parents consented to
participate.
Genetic mapping
Single nucleotide polymorphism (SNP) genotyping was per-
formed in the DNA samples of the two patients and an unaffected
brother, with the Affymetrix GeneChip Human Mapping 250 K
Nsp Array as previously described [28]. Homozygous regions
larger than 2 Mb were manually searched. Selected SNP markers
were used for genotyping the remaining family members. The
carrier rate of the pathogenic mutation was determined by Sanger
sequencing of the relevant exon in DNA samples of 133
anonymous ethnic matched controls.
Exome sequencing
The DNA sample of patient II-2 was enriched for exonic
sequences with the SureSelect Human All Exon v.2 Kit, which
targets 44 Mb (Agilent, Santa Clara, CA, USA). Sequencing was
carried out on a GAIIx (Illumina, San Diego, CA, USA) with 100-
bp paired-end runs. Image analysis and base calling were
performed with the Genome Analyzer Pipeline version 1.5 using
default parameters. The sequence reads were aligned to human
genome assembly hg18 (GRCh36) with DNAnexus software (Palo
Alto, CA) using default parameters.
mRNA quantification
Total RNA was isolated from fibroblasts of patient II-4 and
from five normal unrelated adult controls, using Tri Reagent
(Sigma). DNA traces were removed by treatment with TURBO
DNAse kit (Ambion). RNA was reversed transcribed using
Improm II kit (Ambion) and random hexamers primers. DNA
concentration of two plasmids, one with an ACTB insert and the
other with a cDNA insert encompassing exon 4 and 5 of DNAJC6,
was determined by spectrophotometer. Serial dilution of the
plasmids’ DNA was performed in order to create a calibration
curve on real time PCR instrument (ABI 7900). These calibration
curves were used to determine the copy number of the respective
transcripts in RNA samples from the patient and the controls. We
used the concentration of the ACTB cDNA to normalize the
concentration of the DNAJC6 cDNA and each sample was PCR
four times.
Transferrin uptake in fibroblasts
In order to study the endosomal system, transferrin uptake was
measured in fibroblasts of patient II-2 as previously described [14]
with some modifications. Cells were incubated for 1 h at 37uCi n
labelingmedium(F12containing10 mMHEPES,pH 7.3and0.2%
w/v BSA) to remove unlabeled transferrin. They were then labeled
for 1 h on ice with 50 mg/ml Alexa fluor 488-transferrin (Invitrogen)
in labeling medium. After rinsing twice with warm labeling medium,
they were incubated at 37uC for either 20 or 40 min to allow
transferrin uptake. The cells were then fixed with 2% formaldehyde
in PBS (RT, 30 min) and examined with a Zeiss Axiovert 200
microscope equipped with a 1006oil immersion objective.
Web resources
Online Mendelian Inheritance in Man (OMIM) http://www.
omim.org/ SeattleSeq Annotation website - http://snp.gs.
washington.edu/SeattleSeqAnnotation/ PolyPhen-2 prediction of
functional effects of human nsSNPs http://coot.embl.de/
PolyPhen/ SIFT - Sorting Tolerant From Intolerant http://sift.
jcvi.org/ Mutation taster - http://www.mutationtaster.org/
NHLBI Exome Sequencing Project Exome Variant Server -
http://evs.gs.washington.edu/EVS/.
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